References
- Ahmed S, Marotte H, Kwan K et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc. Natl Acad. Sci. USA105(38), 14692–14697 (2008).
- Haqqi TM, Anthony DD, Gupta S et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc. Natl Acad. Sci. USA96(8), 4524–4529 (1999).
- Kim HR, Rajaiah R, Wu Q-L et al. Green tea protects rats against autoimmune arthritis by modulating disease-related immune events. J. Nutr.138(11), 2111–2116 (2008).
- Marotte H, Ruth JH, Campbell PL, Koch AE, Ahmed S. Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis. Rheumatology49(3), 467–479 (2010).
- Varilek GW, Yang F, Lee EY et al. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J. Nutr.131(7), 2034–2039 (2001).
- Oz HS, Chen TS, McClain CJ, de Villiers WJ. Antioxidants as novel therapy in a murine model of colitis. J. Nutr. Biochem.16(5), 297–304 (2005).
- Ran ZH, Chen C, Xiao SD. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed. Pharmacother.62(3), 189–196 (2008).
- Abboud PA, Hake PW, Burroughs TJ et al. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. Eur. J. Pharmacol.579(1–3), 411–417 (2008).
- Hsu SD, Dickinson DP, Qin H et al. Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren’s syndrome and protect human salivary acinar cells from TNF-α-induced cytotoxicity. Autoimmunity40(2), 138–147 (2007).
- Gillespie K, Kodani I, Dickinson DP et al. Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren’s syndrome, an autoimmune disease. Life Sci.83(17–18), 581–588 (2008).
- Fu Z, Zhen W, Yuskavage J, Liu D. Epigallocatechin gallate delays the onset of Type 1 diabetes in spontaneous non-obese diabetic mice. Br. J. Nutr.105(8), 1218–1225 (2011).
- Aktas O, Prozorovski T, Smorodchenko A et al. Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J. Immunol.173(9), 5794–5800 (2004).
- Pae M, Ren Z, Meydani M, Shang F, Meydani SN, Wu D. Epigallocatechin-3-gallate directly suppresses T cell proliferation through impaired IL-2 utilization and cell cycle progression. J. Nutr.140(8), 1509–1515 (2010).
- Wang J, Ren Z, Xu Y, Xiao S, Meydani SN, Wu D. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T cell subsets. Am. J. Pathol. (2011) (In Press).
- Shanafelt TD, Call TG, Zent CS et al. Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J. Clin. Oncol.27(23), 3808–3814 (2009).
- Mazzanti G, Menniti-Ippolito F, Moro PA et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur. J. Clin. Pharmacol.65(4), 331–341 (2009).
- Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem. Toxicol.48(1), 409–416 (2010).